Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials
BackgroundThe study aims to assess the efficacy and safety of the recently approved S1PR modulator etrasimod in adults with ulcerative colitis during the induction phase through meta-analysis.MethodsA systemic search was performed for randomized controlled trials evaluating the efficacy and safety o...
Saved in:
Main Authors: | Jingyue Qiu (Author), Jiakuo Liu (Author), Kexin Cai (Author), Ting Xu (Author), Wenwen Liu (Author), Fei Lin (Author), Ning Shi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologics for the treatment of moderate- to-severe ulcerative colitis in pediatric patients
by: Albenberg LG, et al.
Published: (2012) -
Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
by: Freeman HJ
Published: (2013) -
The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials
by: Jingyue Qiu, et al.
Published: (2023) -
Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis
by: Peishan Qiu, et al.
Published: (2021) -
Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis
by: M. Galván-Banqueri, et al.
Published: (2015)